Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.

Haiyang Yu | Xuetian Yue | Yuhan Zhao | Xiaoyan Li | Lihua Wu | Cen Zhang | Zhen Liu | Kevin Lin | Zijun Y Xu-Monette | Ken H Young | Juan Liu | Zhiyuan Shen | Zhaohui Feng | Wenwei Hu
Nature communications | 2014

Leukaemia inhibitory factor (LIF) has been recently identified as a p53 target gene, which mediates the role of p53 in maternal implantation under normal physiological conditions. Here we report that LIF is a negative regulator of p53; LIF downregulates p53 protein levels and function in human colorectal cancer (CRC) cells. The downregulation of p53 by LIF is mediated by the activation of Stat3, which transcriptionally induces inhibitor of DNA-binding 1 (ID1). ID1 upregulates MDM2, a key negative regulator of p53, and promotes p53 protein degradation. LIF is overexpressed in a large percentage of CRCs. LIF overexpression promotes cellular resistance towards chemotherapeutic agents in cultured CRC cells and colorectal xenograft tumours in a largely p53-dependent manner. Overexpression of LIF is associated with a poor prognosis in CRC patients. Taken together, LIF is a novel negative regulator of p53, overexpression of LIF is an important mechanism for the attenuation of p53, which promotes chemoresistance in CRCs.

Pubmed ID: 25323535

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: 1 S10 RR025468-01
  • Agency: NCI NIH HHS, United States
    Id: R01 CA160558
  • Agency: NCI NIH HHS, United States
    Id: P30 CA072720
  • Agency: NCRR NIH HHS, United States
    Id: S10 RR025468
  • Agency: NCI NIH HHS, United States
    Id: P30CA072720
  • Agency: NCI NIH HHS, United States
    Id: 1R01CA160558
  • Agency: NCI NIH HHS, United States
    Id: R01 CA143204
  • Agency: NCI NIH HHS, United States
    Id: R01 CA156706
  • Agency: NCI NIH HHS, United States
    Id: 1R01CA143204

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


University of Texas MD Anderson Cancer Center (tool)

RRID:SCR_004699

The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public. VISION: We shall be the premier cancer center in the world, based on the excellence of our people, our research-driven patient care and our science. We are Making Cancer History.

View all literature mentions

p53HCT116 (tool)

RRID:CVCL_S744

Cell line p53HCT116 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCI-H1299 (tool)

RRID:CVCL_0060

Cell line NCI-H1299 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

BALB/cAnNCrl (tool)

RRID:MGI:2683685

laboratory mouse with name BALB/cAnNCrl from MGI.

View all literature mentions

Crl:NU(NCr)-Foxn1nu (tool)

RRID:IMSR_CRL:490

Mus musculus with name Crl:NU(NCr)-Foxn1nu from IMSR.

View all literature mentions

p53HCT116 (tool)

RRID:CVCL_S744

Cell line p53HCT116 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions